세계의 반려동물 의약품 시장 보고서(2025년)

Companion animal pharmaceuticals involve the pharmaceutical medication process where animal pharmacists recommend medications, fill prescriptions, and manage drug therapies for animals. It is utilized in the diagnosis, mitigation, and treatment of various diseases in animals.

The main types of companion animal pharmaceuticals include medications for dogs, cats, horses, and other companion animals. Dogs are highly variable carnivorous domesticated mammals closely related to the common wolf. The indications for these pharmaceuticals cover infectious diseases, dermatologic diseases, pain management, orthopedic diseases, behavioral issues, and other conditions. These medications are typically sold through various distribution channels such as veterinary hospitals, veterinary clinics, and retail pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The companion animal pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides companion animal pharmaceuticals market statistics, including companion animal pharmaceuticals industry global market size, regional shares, competitors with a companion animal pharmaceuticals market share, detailed companion animal pharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the companion animal pharmaceuticals industry. This companion animal pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The companion animal pharmaceuticals market size has grown strongly in recent years. It will grow from $16.49 billion in 2024 to $17.85 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to humanization of pets, preventive healthcare measures, rise in pet insurance, changing lifestyle and urbanization, zoonotic disease concerns, zoonotic disease concerns, veterinary healthcare accessibility.

The companion animal pharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $26.34 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to personalized medicine for pets, telehealth and remote veterinary services, focus on nutrition and nutraceuticals, one health initiatives, expansion of veterinary diagnostic services. Major trends in the forecast period include advancements in veterinary medicine, specialized therapeutics for aging pets, regulatory compliance and safety standards, collaborations and partnerships.

The forecast of 10.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Levies on finished veterinary drugs shipped from the UK and Canada will dampen price competition and reduce generic availability. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of zoonotic diseases is anticipated to drive growth in the companion animal pharmaceuticals market. Zoonotic illnesses, capable of transmission between vertebrate animals and humans, present a considerable public health challenge. In response, the pharmaceutical industry is deploying modern strategies aligned with health principles to combat these diseases and reduce transmission risks. A December 2022 report by the European Centre for Disease Prevention and Control underscores the increasing prevalence of Campylobacteriosis and other zoonotic diseases, highlighting the need for pharmaceutical interventions.

The companion animal pharmaceutical market is poised for growth, fueled by an upsurge in pet ownership. Pet ownership, signifying the human assumption of responsibility for animal care, is on the rise. The market benefits from an expanding pet owner base and a growing recognition of the importance of preventive measures, diagnostics, and treatments for companion animal health. A report from the American Veterinary Medical Association in October 2022 reveals a substantial increase in families owning at least one cat. The trend, supported by increased veterinary spending, underscores the market's growth potential.

The adoption of big data technologies is a noteworthy trend in the companion animal pharmaceuticals sector. Leading companies are actively developing technological solutions to fortify their market positions. Notably, Elanco Animal Health Incorporated and Ginkgo Bioworks launched BiomEdit in April 2022. This microbiome innovation company focuses on developing novel probiotics and related animal pharmaceuticals. The initiative extends to areas such as medicated feed ingredients, nutritional health, therapies for livestock and pets, and biosecurity technologies for monitoring animal illnesses.

Major companies in the companion animal pharmaceutical market are introducing innovative products, such as oral flea and tick treatments, to expand their customer bases, boost sales, and enhance revenue. Oral flea and tick products are medications administered orally to prevent or treat infestations in pets. For example, in October 2024, Elanco Animal Health Incorporated, a US-based pharmaceutical firm, received FDA approval for Credelio Quattro, a new chewable parasiticide formulated for dogs. This product provides monthly protection against six types of parasites, including fleas, ticks, and various internal worms. With the launch of Credelio Quattro, Elanco aims to offer a convenient, comprehensive solution for pet owners seeking broad-spectrum parasite control. This introduction underscores Elanco's commitment to addressing the rising demand for innovative and effective pet health solutions.

In July 2022, Dechra Pharmaceuticals completed the acquisition of Piedmont Animal Health for $210 million. This strategic move enhances Dechra's product portfolio for European and North American markets and augments its scientific and regulatory capabilities. Piedmont Animal Health, a US-based company specializing in companion animal pharmaceuticals, brings complementary offerings to further strengthen Dechra's position in the industry.

Major companies operating in the companion animal pharmaceuticals market are Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma, Eco Animal Health Group PLC, Ashish Life Science Pvt. Ltd., Endovac Animal Health, Hipra Laboratories, Indian Immunologicals Ltd., Inovet Group, Kyoritsu Seiyaku Corporation, Lutim Pharma Pvt. Ltd., Merck & Co. Inc., Norbrook Laboratories Ltd., Tianjin Ringpu Bio-Technology Co. Ltd., Vetoquinol S.A., Virbac S.A., Zoetis Inc., Agrolabo S.p.A., ALS Pvt. Ltd., Zydus Animal Health and Investments Limited, Eli Lilly and Company, IDEXX Laboratories Inc., Merial Limited, Novartis Animal Health Inc., Dechra Pharmaceuticals PLC, Aratana Therapeutics Inc., Phibro Animal Health Corporation, Kindred Biosciences Inc., Jaguar Health Inc., Nexvet Biopharma PLC, Sentinel Biomedical Inc., PetMed Express Inc., Neogen Corporation, Heska Corporation, Synbiotics Corporation, Eurovet Animal Health B.V., Vironova AB, Abaxis Inc., Bioiberica S.A.U., Putney Inc., Lohmann Animal Health International

North America was the largest region in the companion animal pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the companion animal pharmaceuticals market report during the forecast period. The regions covered in the companion animal pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the companion animal pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The companion animal pharmaceuticals market includes revenues earned by entities by providing veterinary pharmaceuticals, vaccines, and health management tools. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Companion Animal Pharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on companion animal pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for companion animal pharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The companion animal pharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Animal Type: Dogs; Cats; Horses; Other Companion Animals
• 2) By Indication: Infectious Diseases; Dermatologic Diseases; Pain; Orthopedic Diseases; Behavioral Diseases; Other Indications
• 3) By Distribution Channels: Veterinary Hospitals; Veterinary Clinics; Retail Pharmacies
• Subsegments:
• 1)By Dogs: Vaccines; Antiparasitic; Anti-Inflammatory Drugs
• 2) By Cats: Vaccines; Antiparasitic; Anti-Inflammatory Drugs
• 3) By Horses: Vaccines; Antiparasitic; Anti-Inflammatory Drugs
• 4) By Other Companion Animals: Vaccines; Antiparasitic; Other Therapeutics
• Companies Mentioned: Elanco Animal Health Incorporated; Boehringer Ingelheim International GmbH; Ceva Sante Animale; Chanelle Pharma; Eco Animal Health Group PLC; Ashish Life Science Pvt. Ltd.; Endovac Animal Health; Hipra Laboratories; Indian Immunologicals Ltd.; Inovet Group; Kyoritsu Seiyaku Corporation; Lutim Pharma Pvt. Ltd.; Merck & Co. Inc.; Norbrook Laboratories Ltd.; Tianjin Ringpu Bio-Technology Co. Ltd.; Vetoquinol S.A.; Virbac S.A.; Zoetis Inc.; Agrolabo S.p.A.; ALS Pvt. Ltd.; Zydus Animal Health and Investments Limited; Eli Lilly and Company; IDEXX Laboratories Inc.; Merial Limited; Novartis Animal Health Inc.; Dechra Pharmaceuticals PLC; Aratana Therapeutics Inc.; Phibro Animal Health Corporation; Kindred Biosciences Inc.; Jaguar Health Inc.; Nexvet Biopharma PLC; Sentinel Biomedical Inc.; PetMed Express Inc.; Neogen Corporation; Heska Corporation; Synbiotics Corporation; Eurovet Animal Health B.V.; Vironova AB; Abaxis Inc.; Bioiberica S.A.U.; Putney Inc.; Lohmann Animal Health International
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Companion Animal Pharmaceuticals Market Characteristics

3. Companion Animal Pharmaceuticals Market Trends And Strategies

4. Companion Animal Pharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Companion Animal Pharmaceuticals Growth Analysis And Strategic Analysis Framework

• 5.1. Global Companion Animal Pharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Companion Animal Pharmaceuticals Market Growth Rate Analysis
• 5.4. Global Companion Animal Pharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Companion Animal Pharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Companion Animal Pharmaceuticals Total Addressable Market (TAM)

6. Companion Animal Pharmaceuticals Market Segmentation

• 6.1. Global Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dogs
• Cats
• Horses
• Other Companion Animals
• 6.2. Global Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Diseases
• Dermatologic Diseases
• Pain
• Orthopedic Diseases
• Behavioral Diseases
• Other Indications
• 6.3. Global Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospitals
• Veterinary Clinics
• Retail Pharmacies
• 6.4. Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Dogs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines
• Antiparasitic
• Anti-Inflammatory Drugs
• 6.5. Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Cats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines
• Antiparasitic
• Anti-Inflammatory Drugs
• 6.6. Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Horses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines
• Antiparasitic
• Anti-Inflammatory Drugs
• 6.7. Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Other Companion Animals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines
• Antiparasitic
• Other Therapeutics

7. Companion Animal Pharmaceuticals Market Regional And Country Analysis

• 7.1. Global Companion Animal Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Companion Animal Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Companion Animal Pharmaceuticals Market

• 8.1. Asia-Pacific Companion Animal Pharmaceuticals Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Companion Animal Pharmaceuticals Market

• 9.1. China Companion Animal Pharmaceuticals Market Overview
• 9.2. China Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Companion Animal Pharmaceuticals Market

• 10.1. India Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Companion Animal Pharmaceuticals Market

• 11.1. Japan Companion Animal Pharmaceuticals Market Overview
• 11.2. Japan Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Companion Animal Pharmaceuticals Market

• 12.1. Australia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Companion Animal Pharmaceuticals Market

• 13.1. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Companion Animal Pharmaceuticals Market

• 14.1. South Korea Companion Animal Pharmaceuticals Market Overview
• 14.2. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Companion Animal Pharmaceuticals Market

• 15.1. Western Europe Companion Animal Pharmaceuticals Market Overview
• 15.2. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Companion Animal Pharmaceuticals Market

• 16.1. UK Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Companion Animal Pharmaceuticals Market

• 17.1. Germany Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Companion Animal Pharmaceuticals Market

• 18.1. France Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Companion Animal Pharmaceuticals Market

• 19.1. Italy Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Companion Animal Pharmaceuticals Market

• 20.1. Spain Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Companion Animal Pharmaceuticals Market

• 21.1. Eastern Europe Companion Animal Pharmaceuticals Market Overview
• 21.2. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Companion Animal Pharmaceuticals Market

• 22.1. Russia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Companion Animal Pharmaceuticals Market

• 23.1. North America Companion Animal Pharmaceuticals Market Overview
• 23.2. North America Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Companion Animal Pharmaceuticals Market

• 24.1. USA Companion Animal Pharmaceuticals Market Overview
• 24.2. USA Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Companion Animal Pharmaceuticals Market

• 25.1. Canada Companion Animal Pharmaceuticals Market Overview
• 25.2. Canada Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Companion Animal Pharmaceuticals Market

• 26.1. South America Companion Animal Pharmaceuticals Market Overview
• 26.2. South America Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Companion Animal Pharmaceuticals Market

• 27.1. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Companion Animal Pharmaceuticals Market

• 28.1. Middle East Companion Animal Pharmaceuticals Market Overview
• 28.2. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Companion Animal Pharmaceuticals Market

• 29.1. Africa Companion Animal Pharmaceuticals Market Overview
• 29.2. Africa Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Companion Animal Pharmaceuticals Market Competitive Landscape And Company Profiles

• 30.1. Companion Animal Pharmaceuticals Market Competitive Landscape
• 30.2. Companion Animal Pharmaceuticals Market Company Profiles
  • 30.2.1. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Chanelle Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eco Animal Health Group PLC Overview, Products and Services, Strategy and Financial Analysis

31. Companion Animal Pharmaceuticals Market Other Major And Innovative Companies

• 31.1. Ashish Life Science Pvt. Ltd.
• 31.2. Endovac Animal Health
• 31.3. Hipra Laboratories
• 31.4. Indian Immunologicals Ltd.
• 31.5. Inovet Group
• 31.6. Kyoritsu Seiyaku Corporation
• 31.7. Lutim Pharma Pvt. Ltd.
• 31.8. Merck & Co. Inc.
• 31.9. Norbrook Laboratories Ltd.
• 31.10. Tianjin Ringpu Bio-Technology Co. Ltd.
• 31.11. Vetoquinol S.A.
• 31.12. Virbac S.A.
• 31.13. Zoetis Inc.
• 31.14. Agrolabo S.p.A.
• 31.15. ALS Pvt. Ltd.

32. Global Companion Animal Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Companion Animal Pharmaceuticals Market

34. Recent Developments In The Companion Animal Pharmaceuticals Market

35. Companion Animal Pharmaceuticals Market High Potential Countries, Segments and Strategies

• 35.1 Companion Animal Pharmaceuticals Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Companion Animal Pharmaceuticals Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Companion Animal Pharmaceuticals Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer